Diminished levels of the chemokine fractalkine in post-mortem prefrontal cortex in schizophrenia but not bipolar disorder

References

• Beasley CL, Honer WG, Bergmann K, Falkai P, Lutjohann D, Bayer TA. 2005. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disorders. 7:449–455.
   PubMed Web of Science ®Google Scholar
• Bergon A, Belzeaux R, Comte M, Pelletier F, Hervé M, Gardiner EJ, Beveridge NJ, Liu B, Carr V, Scott RJ, et al. 2015. CX3CR1 is dysregulated in blood and brain from schizophrenia patients. Schizophr Research. 168:434–443.
   PubMed Web of Science ®Google Scholar
• Bertollini C, Ragozzino D, Gross C, Limatola C, Eusebi F. 2006. Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology. 51:816–821.
   PubMed Web of Science ®Google Scholar
• Busse S, Busse M, Schiltz K, Bielau H, Gos T, Brisch R, Mawrin C, Schmitt A, Jordan W, Müller UJ, et al. 2012. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations? Brain Behav Immun. 26:1273–1279.
   PubMed Web of Science ®Google Scholar
• Clark AK, Yip PK, Grist J, Gentry C, Staniland AA, Marchand F, Dehvari M, Wotherspoon G, Winter J, Ullah J, et al. 2007. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci. USA. 104:10655–10660.
   PubMed Web of Science ®Google Scholar
• Diedenhofen B, Musch J. 2015. cocor: a comprehensive solution for the statistical comparison of correlations. Plos One. 10:e0121945.
   PubMed Web of Science ®Google Scholar
• Dorfman MD, Krull JE, Douglass JD, Fasnacht R, Lara-Lince F, Meek TH, Shi X, Damian V, Nguyen HT, Matsen ME, et al. 2017. Sex differences in microglial CX3CR1 signalling determine obesity susceptibility in mice. Nat Commun. 8:14556.
   PubMed Web of Science ®Google Scholar
• Dubbelaar ML, Kracht L, Eggen BJL, Boddeke E. 2018. The kaleidoscope of microglial phenotypes. Front Immunol. 9:1753
   PubMed Web of Science ®Google Scholar
• Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, Cairns M, Weickert CS. 2013. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 18:206–214.
   PubMed Web of Science ®Google Scholar
• Fonović UP, Jevnikar Z, Kos J. 2013. Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells. Biol Chem. 394:1349–1352.
   PubMed Web of Science ®Google Scholar
• Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. 2001. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem. 276:37993–38001.
   PubMed Web of Science ®Google Scholar
• Gunner G, Cheadle L, Johnson KM, Ayata P, Badimon A, Mondo E, Nagy MA, Liu L, Bemiller SM, Kim KW, et al. 2019. Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling. Nat Neurosci. 22:1075–1088.
   PubMed Web of Science ®Google Scholar
• Hanamsagar R, Alter MD, Block CS, Sullivan H, Bolton JL, Bilbo SD. 2017. Generation of a microglial developmental index in mice and in humans reveals a sex difference in maturation and immune reactivity. Glia. 65:1504–1520.
   PubMed Web of Science ®Google Scholar
• Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, et al. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA. 95:10896–10901.
   PubMed Web of Science ®Google Scholar
• Heinisch S, Kirby LG. 2009. Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuroscience. 164:1210–1223.
   PubMed Web of Science ®Google Scholar
• Honer WG, Young CE. 2004. Presynaptic proteins and schizophrenia. Int Rev Neurobiol. 59:175–199.
   Google Scholar
• Hoseth EZ, Ueland T, Dieset I, Birnbaum R, Shin JH, Kleinman JE, Hyde TM, Mørch RH, Hope S, Lekva T, et al. 2017. A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue. Schizophr Bull. 43:881–890.
   PubMed Web of Science ®Google Scholar
• Huang YW, Su P, Liu GY, Crow MR, Chaukos D, Yan H, Robinson LA. 2009. Constitutive endocytosis of the chemokine CX3CL1 prevents its degradation by cell surface metalloproteases. J Biol Chem. 284:29644–29653.
   PubMed Web of Science ®Google Scholar
• Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, et al. 2003. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 102:1186–1195.
   PubMed Web of Science ®Google Scholar
• Ishizuka K, Fujita Y, Kawabata T, Kimura H, Iwayama Y, Inada T, Okahisa Y, Egawa J, Usami M, Kushima I, et al. 2017. Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders. Transl Psychiatry. 7:e1184.
   PubMed Web of Science ®Google Scholar
• Juncal-Ruiz M, Riesco-Dávila L, Ortiz-García de la Foz V, Martínez-Garcia O, Ramírez-Bonilla M, Ocejo-Viñals JG, Leza JC, López-Hoyos M, Crespo-Facorro B. 2018. Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: a 3 months randomized study. Schizophr Res. 202:226–233.
   PubMed Web of Science ®Google Scholar
• Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR. 2000. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol. 20:4106–4114.
   PubMed Web of Science ®Google Scholar
• Lyons A, Lynch AM, Downer EJ, Hanley R, O’Sullivan JB, Smith A, Lynch MA. 2009. Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attenuates microglial activation in vivo and in vitro. J Neurochem. 110:1547–1556.
   PubMed Web of Science ®Google Scholar
• Mizuno T, Kawanokuchi J, Numata K, Suzumura A. 2003. Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 979:65–70.
   PubMed Web of Science ®Google Scholar
• Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, Cardona AE. 2012. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol. 188:29–36.
   PubMed Web of Science ®Google Scholar
• Müller N. 2018. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull. 44:973–982.
   PubMed Web of Science ®Google Scholar
• NCBI Resource Coordinators. 2018. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 46:D8–D13.
   PubMed Web of Science ®Google Scholar
• Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, Satoh M. 1998. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett. 429:167–172.
   PubMed Web of Science ®Google Scholar
• Padmos RC, Hillegers MHJ, Knijff EM, Vonk R, Bouvy A, Staal FJT, de Ridder D, Kupka RW, Nolen WA, Drexhage HA. 2008. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 65:395–407.
   PubMed Web of Science ®Google Scholar
• Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, Conley RR, Dwivedi Y. 2012. Proinflammatory Cytokines in the Prefrontal Cortex of Teenage Suicide Victims. J Psychiatr Res. 46:57–63.
   PubMed Web of Science ®Google Scholar
• Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Duma L, et al. 2011. Synaptic pruning by microglia is necessary for normal brain development. Science. 333:1456–1458.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2019. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org/.
   Google Scholar
• Rosenblat JD, McIntyre RS. 2017. Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci. 7:144.
   PubMed Web of Science ®Google Scholar
• Shao L, Golbaz K, Honer WG, Beasley CL. 2016. Deficits in axon-associated proteins in prefrontal white matter in bipolar disorder but not schizophrenia. Bipolar Disord. 18:342–351.
   Google Scholar
• Sneeboer MAM, Snijders G, Berdowski WM, Fernández-Andreu A, van Mierlo HC, van Berlekom AB, Litjens M, Kahn RS, Hol EM, de Witte LD; Psychiatric Donor Program of the Netherlands Brain Bank (NBB-Psy). 2019. Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated. Transl Psychiatry. 9:10.
   PubMed Web of Science ®Google Scholar
• Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein HG, Bogerts B. 2008. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 42:151–157.
   PubMed Web of Science ®Google Scholar
• Steiner J, Mawrin C, Ziegeler A, Bielau H, Ullrich O, Bernstein HG, Bogerts B. 2006. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. 112:305–316.
   PubMed Web of Science ®Google Scholar
• Tay TL, Béchade C, D'Andrea I, St-Pierre MK, Henry MS, Roumier A, Tremblay ME. 2018. Microglia gone rogue: impacts on psychiatric disorders across the lifespan. Front Mol Neurosci. 10:421.
   PubMed Web of Science ®Google Scholar
• Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. 2000. The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr Res. 44:151–155.
   PubMed Web of Science ®Google Scholar
• Trépanier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP. 2016. Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry. 21:1009–1026.
   PubMed Web of Science ®Google Scholar
• Tsou CL, Haskell CA, Charo IF. 2001. Tumor necrosis factor-α-converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem. 276:44622–44626.
   PubMed Web of Science ®Google Scholar
• Volk DW, Chitrapu A, Edelson JR, Roman KM, Moroco AE, Lewis DA. 2015. Molecular mechanisms and timing of cortical immune activation in schizophrenia. AJP. 172:1112–1121.
   Web of Science ®Google Scholar
• Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F, Vyssotski AL, Bifone A, Gozzi A, Ragozzino D, et al. 2014. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci. 17:400–406.
   PubMed Web of Science ®Google Scholar
• Zhang L, Verwer RWH, Lucassen PJ, Huitinga I, Swaab DF. 2020. Prefrontal cortex alterations in glia gene expression in schizophrenia with and without suicide. J Psychiatr Res. 121:31–38.
   PubMed Web of Science ®Google Scholar
• Zujovic V, Benavides J, Vigé X, Carter C, Taupin V. 2000. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia. 29:305–315.
   PubMed Web of Science ®Google Scholar